Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma Article

Kotecha, Rupesh, Polley, Mei-Yin, Vogelbaum, Michael A et al. (2026). Long-Term Analysis of NRG Oncology RTOG 0539: A Phase II Trial of Observation for Low-Risk Meningioma and Radiotherapy for Intermediate- and High-Risk Meningioma . JOURNAL OF CLINICAL ONCOLOGY, 44(23), 2169-2175. 10.1200/JCO-25-01441

cited authors

  • Kotecha, Rupesh; Polley, Mei-Yin; Vogelbaum, Michael A; Perry, Arie; Ashby, Lynn; Modi, Jignesh M; Alleman, Anthony M; Tsien, Christina I; Barani, Igor Johan; Li, Jing; Braunstein, Steve; Whitton, Anthony C; Bovi, Joseph A; Deb, Nimisha; Lindhorst, Scott M; Shrieve, Dennis C; Robinson, Clifford G; Shu, Hui-Kuo G; Vempati, Prashant; Mishra, Mark Vikas; Suh, John H; Bloom, Beatrice; Hunter, Grant K; Won, Minhee; Mehta, Minesh P; Rogers, C Leland

authors

publication date

  • August 10, 2026

published in

keywords

  • CLASSIFICATION
  • Life Sciences & Biomedicine
  • Oncology
  • Science & Technology

Digital Object Identifier (DOI)

publisher

  • LIPPINCOTT WILLIAMS & WILKINS

start page

  • 2169

end page

  • 2175

volume

  • 44

issue

  • 23